Phase I study of intraperitoneal TRX-E-002-1 in subjects with persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer: Three-month follow-up results of the dose escalation phase
Keyword(s):
Phase I
◽
2019 ◽
2019 ◽
2015 ◽
Vol 33
(15_suppl)
◽
pp. 5507-5507
◽
2018 ◽
Vol 36
(15_suppl)
◽
pp. 5580-5580
2015 ◽
Vol 33
(15_suppl)
◽
pp. 5541-5541
◽